Oscar Health (OSCR) to Release Quarterly Earnings on Tuesday

Oscar Health (NYSE:OSCR) is scheduled to release its earnings data before the market opens on Tuesday, May 7th. Analysts expect Oscar Health to post earnings of $0.28 per share for the quarter. Oscar Health has set its FY 2024 guidance at EPS.Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Wednesday, February 7th. The company reported ($0.66) earnings per share for the quarter, beating the consensus estimate of ($0.74) by $0.08. The firm had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.43 billion. Oscar Health had a negative net margin of 4.62% and a negative return on equity of 29.99%. The company’s revenue was up 43.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($1.05) EPS. On average, analysts expect Oscar Health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Oscar Health Trading Down 0.9 %

Shares of OSCR stock opened at $17.40 on Tuesday. The company’s 50-day moving average price is $15.23 and its 200-day moving average price is $11.41. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.37. The stock has a market cap of $4.00 billion, a price-to-earnings ratio of -14.50 and a beta of 1.79. Oscar Health has a twelve month low of $4.72 and a twelve month high of $18.55.

Analysts Set New Price Targets

Several brokerages have recently weighed in on OSCR. Raymond James began coverage on shares of Oscar Health in a research report on Friday, March 22nd. They set an “outperform” rating and a $20.00 price target on the stock. Wells Fargo & Company boosted their price objective on shares of Oscar Health from $12.00 to $20.00 and gave the company an “overweight” rating in a report on Thursday, February 15th. The Goldman Sachs Group boosted their price objective on shares of Oscar Health from $8.00 to $16.00 and gave the company a “neutral” rating in a report on Friday, February 9th. Finally, TheStreet upgraded shares of Oscar Health from a “d” rating to a “c-” rating in a report on Wednesday, February 21st. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $13.50.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.